More from Dividend.com
Referenced Stocks

Bristol-Myers to Purchase Diabetes Drug Maker Amylin Pharmaceuticals for $5.3 Billion in Cash (BMY)

By Dividend.com,  July 02, 2012, 08:26:14 AM EDT

Pharmaceutical giant Bristol-Myers Squibb Co. ( BMY ) late Friday announced it has entered into an agreement to buy fellow pharma company Amylin Pharmaceuticals ( AMLN ) .

The $5.3 billion purchase, or $31 per share for AMLN, represents about a 10% premium over the stock's Friday closing price of $28.20. The deal has been approved by both companies' board of directors.

Amylin is a leading diabetes drug maker, with two new treatments called Byetta and Bydureon. After the deal is completed, Bristol-Myers will collaborate with AstraZeneca ( AZN ) on the drugs, according to existing deals between AMLN and AZN. AstraZeneca will also pay $3.4 billion to Amylin in pursuant to the deal.

Bristol-Myers CEO Lamberto Andreotti commented, "Amylin's innovative diabetes portfolio, talented people and state-of-the art manufacturing facility complement our long-standing leadership in metabolics. We are pleased to be able to strengthen the portfolio we have built to help patients with diabetes by building on the success Amylin has had with its GLP-1 franchise. The acquisition of Amylin by Bristol-Myers Squibb is also a unique way for Bristol-Myers Squibb and AstraZeneca to expand the alliance between the two companies, and it demonstrates Bristol-Myers Squibb's innovative and targeted approach to partnerships and business development."

Bristol-Myers shares were mostly flat in premarket trading Monday.

The Bottom Line
Bristol-Myers currently offers a 3.78% dividend yield, based on Friday's closing price of $35.95.

Bristol Myers Squibb Co. ( BMY ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Stocks

Referenced Stocks: BMY



Latest News Video

Winning Ticket Sold in Record Multi-Million Dollar Lottery
Winning Ticket Sold in Record Multi...
Man, Not Economy, in Crisis, Says Pope
Man, Not Economy, in Crisis, Says P...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.43 0.07  0.52%
CSCO $ 24.24 0.35  1.48%
MSFT $ 34.87 0.79  2.32%
F $ 15.08 0.44  3.01%
ARUN $ 13.10 4.51  25.61%
SIRI $ 3.50 0.05  1.45%
GE $ 23.46 0.19  0.82%
S $ 7.32 0.04  0.55%